Xiaoli Ji
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xiaoli Ji has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
Shipeng Zhang
Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People’s Republic of China
3 shared publicationsXiulian Zhuang
Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, People’s Republic of China
3 shared publicationsChang Cai
Clinical Medical College, Chengdu University of Traditional Chinese Medicine, Chengdu, China
2 shared publicationsJiali Yin
Clinical Medical College, Chengdu University of Traditional Chinese Medicine, Chengdu, China
2 shared publications- Li Huang
Department of Gynecology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China
2 shared publications Rui Fu
Clinical Medical College, Chengdu University of Traditional Chinese Medicine, Chengdu, China
2 shared publications
Latest Publications
- 2 June 2026
- Published by Springer Nature in Journal of Neurology
- Vol. 273 (6) , 353
Association of combined ultra-processed food intake (ultra-processed dietary pattern) with cognitive function impairment: a meta-analysis of prospective cohort studies
Background Previous studies on ultra-processed foods (UPF) and cognitive impairment often isolated UPF from overall dietary patterns, limiting real-world interpretation. Methods We systematically searched PubMed, Embase, Web of Science, and Cochrane Library up to April 2026 for prospective cohort studies assessing total UPF intake (defined by NOVA) and risk of cognitive impairment (including cognitive dysfunction, dementia, and Alzheimer’s disease). A random-effects model was used to pool adjusted hazard ratios (HRs) comparing highest versus lowest UPF consumption. Results Eight cohort studies (total > 250,000 participants) were included. High combined UPF intake was associated with a 14% higher risk of cognitive impairment (pooled HR = 1.14, 95%CI 1.04–1.25, I2 = 64.6%). The association was more pronounced in participants aged < 60 years (HR = 1.19, 95%CI 1.06–1.33) but not statistically significant in those > 60 years. Large studies (> 10,000) and longer follow-up (> 15 years) showed stable estimates with lower heterogeneity. Conclusion Higher consumption of UPF within a ultra-processed dietary context is positively associated with cognitive impairment risk, particularly among middle-aged adults. These findings support dietary guidelines that recommend limiting UPF intake.
- 2 June 2026
- Published by Springer Nature in Journal of Neurology
- Vol. 273 (6) , 353
Association of combined ultra-processed food intake (ultra-processed dietary pattern) with cognitive function impairment: a meta-analysis of prospective cohort studies
Background Previous studies on ultra-processed foods (UPF) and cognitive impairment often isolated UPF from overall dietary patterns, limiting real-world interpretation. Methods We systematically searched PubMed, Embase, Web of Science, and Cochrane Library up to April 2026 for prospective cohort studies assessing total UPF intake (defined by NOVA) and risk of cognitive impairment (including cognitive dysfunction, dementia, and Alzheimer’s disease). A random-effects model was used to pool adjusted hazard ratios (HRs) comparing highest versus lowest UPF consumption. Results Eight cohort studies (total > 250,000 participants) were included. High combined UPF intake was associated with a 14% higher risk of cognitive impairment (pooled HR = 1.14, 95%CI 1.04–1.25, I2 = 64.6%). The association was more pronounced in participants aged < 60 years (HR = 1.19, 95%CI 1.06–1.33) but not statistically significant in those > 60 years. Large studies (> 10,000) and longer follow-up (> 15 years) showed stable estimates with lower heterogeneity. Conclusion Higher consumption of UPF within a ultra-processed dietary context is positively associated with cognitive impairment risk, particularly among middle-aged adults. These findings support dietary guidelines that recommend limiting UPF intake.
- Open Access
- 29 April 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
A case control study of subjective sleep characteristics and polycystic ovary syndrome
To investigate the subjective sleep characteristics of patients with polycystic ovary syndrome (PCOS) and their association with the syndrome. A case-control study was conducted, enrolling 136 patients with PCOS and 164 non-PCOS controls recruited from the gynecology outpatient department between February and October 2025. Sleep quality was assessed using a simplified questionnaire derived from core items of the Pittsburgh Sleep Quality Index. Multivariate logistic regression analysis was performed to evaluate the association between sleep problems and PCOS, with adjustment for age, body mass index (BMI), and other potential confounders. The PCOS group exhibited significantly higher prevalences of difficulty falling asleep (51.5% vs. 32.3%), non-restorative sleep (51.5% vs. 32.9%), and self-reported poor sleep quality (66.2% vs. 53.7%) compared with the control group (all p < 0.05). The prevalence of frequent dreaming was significantly higher in the PCOS group than in the control group (39.0% vs. 28.0%, p = 0.045, chi-square test). However, in the correlation analysis, frequent dreaming was not significantly associated with PCOS status ( p > 0.05). After adjustment for potential confounders, participants with moderate and high sleep problem scores demonstrated a significantly increased risk of PCOS (moderate group: adjusted odds ratio [aOR] = 1.845, 95% CI: 1.025–3.320; high group: aOR = 2.286, 95% CI: 1.054–4.959). Subjective sleep disturbances are highly prevalent among patients with PCOS, particularly characterized by difficulty falling asleep, non-restorative sleep, and perceived poor sleep quality. The severity of these sleep disturbances is independently associated with an increased risk of PCOS. Subjective sleep assessment should be incorporated into the clinical management of PCOS.
- 29 April 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessA case control study of subjective sleep characteristics and polycystic ovary syndrome
To investigate the subjective sleep characteristics of patients with polycystic ovary syndrome (PCOS) and their association with the syndrome. A case-control study was conducted, enrolling 136 patients with PCOS and 164 non-PCOS controls recruited from the gynecology outpatient department between February and October 2025. Sleep quality was assessed using a simplified questionnaire derived from core items of the Pittsburgh Sleep Quality Index. Multivariate logistic regression analysis was performed to evaluate the association between sleep problems and PCOS, with adjustment for age, body mass index (BMI), and other potential confounders. The PCOS group exhibited significantly higher prevalences of difficulty falling asleep (51.5% vs. 32.3%), non-restorative sleep (51.5% vs. 32.9%), and self-reported poor sleep quality (66.2% vs. 53.7%) compared with the control group (all p < 0.05). The prevalence of frequent dreaming was significantly higher in the PCOS group than in the control group (39.0% vs. 28.0%, p = 0.045, chi-square test). However, in the correlation analysis, frequent dreaming was not significantly associated with PCOS status ( p > 0.05). After adjustment for potential confounders, participants with moderate and high sleep problem scores demonstrated a significantly increased risk of PCOS (moderate group: adjusted odds ratio [aOR] = 1.845, 95% CI: 1.025–3.320; high group: aOR = 2.286, 95% CI: 1.054–4.959). Subjective sleep disturbances are highly prevalent among patients with PCOS, particularly characterized by difficulty falling asleep, non-restorative sleep, and perceived poor sleep quality. The severity of these sleep disturbances is independently associated with an increased risk of PCOS. Subjective sleep assessment should be incorporated into the clinical management of PCOS.
- Top Cited PapersOpen Access
- 21 March 2026
- Published by Springer Nature in Biomarker Research
- Vol. 14
Multi-omics biomarkers in female fertility: from oocyte quality to endometrial receptivity and clinical translation
High-throughput omics technologies have transformed our understanding of female reproductive biology, revealing molecular interactions governing oocyte mat
- 21 March 2026
- Published by Springer Nature in Biomarker Research
- Vol. 14
Top Cited PapersOpen AccessMulti-omics biomarkers in female fertility: from oocyte quality to endometrial receptivity and clinical translation
High-throughput omics technologies have transformed our understanding of female reproductive biology, revealing molecular interactions governing oocyte mat
- Open Access
- 25 February 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1734108
Methodological improvements are needed in network meta analyses of antidiabetic drugs for type 2 diabetes mellitus
Introduction: Numerous network meta-analyses have compared the efficacy of antidiabetic drugs for type 2 diabetes mellitus. However, a systematic assessment of their methodological and reporting quality remains lacking. Methods: We searched the PubMed, Embase, and Cochrane Library databases for relevant studies from inception to July 21, 2025 for published network meta-analyses that compares the efficacy of antidiabetic drugs for type 2 diabetes mellitus. The methodological and reporting quality of included studies was assessed by the Assessment of Multiple Systematic Reviews 2 checklist and the PRISMA-NMA checklist. Regression analyses were performed to identify factors potentially associated with the methodological quality of the included studies. Results: A total of 185 NMAs were included. Over half of the studies (58.38%) originated from developing countries. Most studies focused on comparison of multiple antidiabetic drugs (122, 65.95%), and the majority used Bayesian methods (98, 52.97%). The overall methodological quality was low, with only one study rated as high quality. Critical items of AMSTAR 2 were poorly reported, with only 2.70% of studies adequately reporting item 7 and 58.38% reporting item 2. Significant associations were observed between study quality and analytical framework, outcome, economic development level, journal impact factor, and protocol registration status. Conclusion: Network meta-analyses that compares antidiabetic drugs for T2DM exhibit substantial methodological limitations and advancements in methodology are critically needed in future research.
- 25 February 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1734108
Open AccessMethodological improvements are needed in network meta analyses of antidiabetic drugs for type 2 diabetes mellitus
Introduction: Numerous network meta-analyses have compared the efficacy of antidiabetic drugs for type 2 diabetes mellitus. However, a systematic assessment of their methodological and reporting quality remains lacking. Methods: We searched the PubMed, Embase, and Cochrane Library databases for relevant studies from inception to July 21, 2025 for published network meta-analyses that compares the efficacy of antidiabetic drugs for type 2 diabetes mellitus. The methodological and reporting quality of included studies was assessed by the Assessment of Multiple Systematic Reviews 2 checklist and the PRISMA-NMA checklist. Regression analyses were performed to identify factors potentially associated with the methodological quality of the included studies. Results: A total of 185 NMAs were included. Over half of the studies (58.38%) originated from developing countries. Most studies focused on comparison of multiple antidiabetic drugs (122, 65.95%), and the majority used Bayesian methods (98, 52.97%). The overall methodological quality was low, with only one study rated as high quality. Critical items of AMSTAR 2 were poorly reported, with only 2.70% of studies adequately reporting item 7 and 58.38% reporting item 2. Significant associations were observed between study quality and analytical framework, outcome, economic development level, journal impact factor, and protocol registration status. Conclusion: Network meta-analyses that compares antidiabetic drugs for T2DM exhibit substantial methodological limitations and advancements in methodology are critically needed in future research.
- Open Access
- 4 February 2025
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 12, 1538405
Association between the intake of potentially risky beverages and the occurrence of endometrial polyps: a case–control study
Background: This case–control study aimed to examine the association between the frequency of potentially risky beverage consumption, levels of anxiety, and the prevalence of endometrial polyps.Methods: A total of 418 participants were enrolled in the study, comprising 206 cases and 212 controls. The case group consisted of patients who visited the gynecological clinic at the Affiliated Hospital of Chengdu University of Traditional Chinese Medicine and were diagnosed with endometrial polyps (Eps) based on international diagnostic criteria. The control group consisted of women of childbearing age who visited the gynecological clinic with similar clinical symptoms but did not have EPs. Basic information, consumption of potentially risky beverages (PRB), and anxiety levels for both groups were collected through a questionnaire survey. Finally, the relationship between the frequency of PRB consumption, anxiety levels, and the prevalence of EPs was evaluated.Results: In this study, we identified a significant positive association between the consumption of PRB and the prevalence of EPs. PRB intake was categorized into three groups based on the cumulative total score: 5–8 for the Low potentially risky beverages (LPRB) intake group, 9–12 for the medium potentially risky beverages (MPRB) intake group, and 13–21 for the high potentially risky beverages (HPRB) intake group. The results revealed that PRB consumption frequency was significantly associated with EPs (OR: 2.348, 95% CI: 1.153–4.78), with higher PRB intake correlating with an increased risk of EPs (p-value: 0.014). However, no significant difference was observed between the LPRB, MPRB, HPRB intake frequency groups and the different levels of anxiety (p-value: 0.793).Conclusion: Increased consumption of PRB was clearly associated with a greater risk of EPs, and over half of the participants exhibited varying degrees of anxiety. These findings suggest that the risk of EPs can be mitigated by controlling beverage intake and highlight the need for increased attention to women’s mental health.Clinical trial registration: NCT06295510.
- 4 February 2025
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 12, 1538405
Open AccessAssociation between the intake of potentially risky beverages and the occurrence of endometrial polyps: a case–control study
Background: This case–control study aimed to examine the association between the frequency of potentially risky beverage consumption, levels of anxiety, and the prevalence of endometrial polyps.Methods: A total of 418 participants were enrolled in the study, comprising 206 cases and 212 controls. The case group consisted of patients who visited the gynecological clinic at the Affiliated Hospital of Chengdu University of Traditional Chinese Medicine and were diagnosed with endometrial polyps (Eps) based on international diagnostic criteria. The control group consisted of women of childbearing age who visited the gynecological clinic with similar clinical symptoms but did not have EPs. Basic information, consumption of potentially risky beverages (PRB), and anxiety levels for both groups were collected through a questionnaire survey. Finally, the relationship between the frequency of PRB consumption, anxiety levels, and the prevalence of EPs was evaluated.Results: In this study, we identified a significant positive association between the consumption of PRB and the prevalence of EPs. PRB intake was categorized into three groups based on the cumulative total score: 5–8 for the Low potentially risky beverages (LPRB) intake group, 9–12 for the medium potentially risky beverages (MPRB) intake group, and 13–21 for the high potentially risky beverages (HPRB) intake group. The results revealed that PRB consumption frequency was significantly associated with EPs (OR: 2.348, 95% CI: 1.153–4.78), with higher PRB intake correlating with an increased risk of EPs (p-value: 0.014). However, no significant difference was observed between the LPRB, MPRB, HPRB intake frequency groups and the different levels of anxiety (p-value: 0.793).Conclusion: Increased consumption of PRB was clearly associated with a greater risk of EPs, and over half of the participants exhibited varying degrees of anxiety. These findings suggest that the risk of EPs can be mitigated by controlling beverage intake and highlight the need for increased attention to women’s mental health.Clinical trial registration: NCT06295510.
- 3 May 2024
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 207,p. e66438
Acupoint Catgut Embedding for Treatment of Chronic Pelvic Pain due to the Sequelae of Pelvic Inflammatory Disease
Chronic pelvic pain caused by the sequelae of inflammatory pelvic disease is a common clinical condition of pelvic pain in women. At present, the main challenges in its treatment are the limited effectiveness of pain relief and the frequent recurrence of symptoms, which significantly impact patients' quality of life and impose a considerable psychological burden on them. It is a clinically challenging disease. After summarizing years of treatment experience, the author's team discovered that acupoint catgut embedding demonstrated notable clinical efficacy in managing chronic pelvic pain stemming from pelvic inflammatory disease sequelae. Compared to existing Western medicine treatment methods, acupoint catgut embedding offers advantages such as a good analgesic effect, lower recurrence rate, economic benefits, and a relatively straightforward procedure. This article provides a comprehensive guide on embedding absorbable catgut into patients' acupoints for the treatment of chronic pelvic pain in females resulting from the sequelae of pelvic inflammatory disease.
- 3 May 2024
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 207,p. e66438
Acupoint Catgut Embedding for Treatment of Chronic Pelvic Pain due to the Sequelae of Pelvic Inflammatory Disease
Chronic pelvic pain caused by the sequelae of inflammatory pelvic disease is a common clinical condition of pelvic pain in women. At present, the main challenges in its treatment are the limited effectiveness of pain relief and the frequent recurrence of symptoms, which significantly impact patients' quality of life and impose a considerable psychological burden on them. It is a clinically challenging disease. After summarizing years of treatment experience, the author's team discovered that acupoint catgut embedding demonstrated notable clinical efficacy in managing chronic pelvic pain stemming from pelvic inflammatory disease sequelae. Compared to existing Western medicine treatment methods, acupoint catgut embedding offers advantages such as a good analgesic effect, lower recurrence rate, economic benefits, and a relatively straightforward procedure. This article provides a comprehensive guide on embedding absorbable catgut into patients' acupoints for the treatment of chronic pelvic pain in females resulting from the sequelae of pelvic inflammatory disease.
- Open Access
- 5 September 2022
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2022, 1-13
Shipi Shugan Decoction Protected against Sequela of Pelvic Inflammatory Disease via Inhibiting SIRT1/NLRP3 Signaling Pathway in Pelvic Inflammatory Disease Rats
Sequela of pelvic inflammatory disease (SPID) is a common and frequently occurring disease clinically. Traditional Chinese medicine (TCM) provided unique advantages in the treatment of SPID. In this study, we aimed to investigate the protective mechanism of Shipi Shugan Decoction (SSD), a Chinese herbal formula, on SPID using a SPID rat model. Mixed bacterial infection and mechanical injury were used for modeling. The chemical composition of SSD was analyzed by ultra-performance liquid chromatography-mass spectrometry (UPLC-MS). The inflammatory factors were detected by enzyme-linked immunosorbent assay (ELISA) and western blot techniques. We found that SSD dose-dependently inhibited the content of IL-18, IL-1β, TNF-α, and IL-6 in serum samples of SPID rats. The results from the hematoxylin and eosin (H&E) stain showed that SSD improved pathological injury of the uterus and fallopian tubes induced by a pathogen. In addition, SSD dose-dependently inhibited mitochondrial dysfunction and oxidative stress of SPID rats. The expression of SIRT1 was promoted, and NLRP3 inflammasome was deactivated by SSD gavage compared with the SPID group. Specifically, SIRT1 inhibitor EX-527 cotreatment significantly reversed the improvement effect of SSD on pelvic inflammatory disease in rats. Taken together, the results of this study suggest that Shipi Shugan Decoction may be an effective TCM for the treatment of SPID.
- 5 September 2022
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2022, 1-13
Open AccessShipi Shugan Decoction Protected against Sequela of Pelvic Inflammatory Disease via Inhibiting SIRT1/NLRP3 Signaling Pathway in Pelvic Inflammatory Disease Rats
Sequela of pelvic inflammatory disease (SPID) is a common and frequently occurring disease clinically. Traditional Chinese medicine (TCM) provided unique advantages in the treatment of SPID. In this study, we aimed to investigate the protective mechanism of Shipi Shugan Decoction (SSD), a Chinese herbal formula, on SPID using a SPID rat model. Mixed bacterial infection and mechanical injury were used for modeling. The chemical composition of SSD was analyzed by ultra-performance liquid chromatography-mass spectrometry (UPLC-MS). The inflammatory factors were detected by enzyme-linked immunosorbent assay (ELISA) and western blot techniques. We found that SSD dose-dependently inhibited the content of IL-18, IL-1β, TNF-α, and IL-6 in serum samples of SPID rats. The results from the hematoxylin and eosin (H&E) stain showed that SSD improved pathological injury of the uterus and fallopian tubes induced by a pathogen. In addition, SSD dose-dependently inhibited mitochondrial dysfunction and oxidative stress of SPID rats. The expression of SIRT1 was promoted, and NLRP3 inflammasome was deactivated by SSD gavage compared with the SPID group. Specifically, SIRT1 inhibitor EX-527 cotreatment significantly reversed the improvement effect of SSD on pelvic inflammatory disease in rats. Taken together, the results of this study suggest that Shipi Shugan Decoction may be an effective TCM for the treatment of SPID.